http://www.oncologynurseadvisor.com/drug-information/topic/8045/ Articles tagged with Drug Information from ONA ONA Admin@haymarketmedia.com no Leukemia experts call for examination of the 'right' way to price life-saving drugs http://www.oncologynurseadvisor.com/experts-aim-to-draw-attention-to-high-cancer-drug-costs/article/293190/ Tue, 14 May 2013 13:00:00 GMT Leukemia experts call for examination of the 'right' way to price life-saving drugs ONA Axitinib is a multitargeted TKI indicated for the treatment of advanced RCC after failure of one prior systemic therapy. http://www.oncologynurseadvisor.com/axitinib-inlyta/article/290211/ Wed, 08 May 2013 14:00:00 GMT Axitinib is a multitargeted TKI indicated for the treatment of advanced RCC after failure of one prior systemic therapy. ONA The FDA has designated Merck's lambrolizumab (MK-3475) as Breakthrough Therapy for the treatment of patients with advanced melanoma. Lambrolizumab is an investigational antibody therapy targeting Programmed Death receptor. http://www.oncologynurseadvisor.com/lambrolizumab-given-breakthrough-therapy-designation-for-advanced-melanoma/article/292056/ Mon, 06 May 2013 11:00:00 GMT The FDA has designated Merck's lambrolizumab (MK-3475) as Breakthrough Therapy for the treatment of patients with advanced melanoma. Lambrolizumab is an investigational antibody therapy targeting Programmed Death receptor. ONA The U.S. Food and Drug Administration has announced the launch of a new interactive tool for educating patients, their advocates, and consumers about the processes involved in medication development. http://www.oncologynurseadvisor.com/interactive-tool-from-fda-educates-patients-about-drug-development/article/291027/ Wed, 01 May 2013 18:00:00 GMT The U.S. Food and Drug Administration has announced the launch of a new interactive tool for educating patients, their advocates, and consumers about the processes involved in medication development. ONA Does consumption of regular orange juice cause drug interactions, or should all citrus fruits be avoided? http://www.oncologynurseadvisor.com/consuming-regular-orange-juice-during-drug-therapy/article/289384/ Mon, 29 Apr 2013 15:33:00 GMT Does consumption of regular orange juice cause drug interactions, or should all citrus fruits be avoided? ONA Which medicines can be split or crushed for administration? http://www.oncologynurseadvisor.com/splitting-or-crushing-oral-cancer-medications/article/288575/ Thu, 18 Apr 2013 14:00:00 GMT Which medicines can be split or crushed for administration? ONA This column reviews the latest FDA drug news, including approvals for Kadcyla, Stivarga, Pomalidomide, and Lymphoseek. http://www.oncologynurseadvisor.com/fda-update-kadcyla-approved-and-more-drug-news/article/288573/ Tue, 16 Apr 2013 11:00:00 GMT This column reviews the latest FDA drug news, including approvals for Kadcyla, Stivarga, Pomalidomide, and Lymphoseek. ONA Is CYP2D6 genotyping for tamoxifen (Nolvadex) sensitivity before use of the drug beneficial? http://www.oncologynurseadvisor.com/genotype-testing-not-warranted/article/286626/ Fri, 29 Mar 2013 12:19:46 GMT Is CYP2D6 genotyping for tamoxifen (Nolvadex) sensitivity before use of the drug beneficial? ONA How soon should the creatinine be measured when dosing carboplatin (Paraplatin)? http://www.oncologynurseadvisor.com/inclusion-of-creatinine-in-blood-work-during-carboplatin-treatment/article/284837/ Mon, 18 Mar 2013 16:12:40 GMT How soon should the creatinine be measured when dosing carboplatin (Paraplatin)? ONA The protein HER2 plays a role even in breast cancers that would traditionally be categorized as HER2-negative. The drug trastuzumab (Herceptin), which targets HER2, may have an even greater role for treating breast cancer and preventing its spread. http://www.oncologynurseadvisor.com/trastuzumab-may-also-be-effective-for-women-with-her2-negative-breast-cancer/article/283475/ Fri, 08 Mar 2013 00:00:00 GMT The protein HER2 plays a role even in breast cancers that would traditionally be categorized as HER2-negative. The drug trastuzumab (Herceptin), which targets HER2, may have an even greater role for treating breast cancer and preventing its spread. ONA